A Registered Cohort Study on α-Synucleinopathy
α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom. The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of
| Condition(s) | α-synucleinopathy |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom. The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of α-synucleinopathy. |
| Who can participate | Inclusion Criteria: * Participants with a clinical diagnosis of primary α-synucleinopathy * Unrelated healthy controls Exclusion Criteria: * Patients with secondary α-synucleinopathy that cannot be excluded. * Patients with other neurological disorders. * Pregnant or lactating women. |
| Ages | 30 Years to 80 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Fujian Medical University Union Hospital |
| Locations | Fuzhou, Fujian, China |
| Start date | 2021-09-01 |
| NCT ID | NCT05527067 |
| Official listing | https://clinicaltrials.gov/study/NCT05527067 |